Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians' Practices across Six Randomised Controlled Trials

Leila Rooshenas, Daisy Elliott, Julia Wade, Marcus Jepson, Sangeetha Paramasivan, Sean Strong, Caroline Wilson, David Beard, Jane M Blazeby, Alison Birtle, Alison Halliday, Chris A Rogers, Rob Stein, Jenny L Donovan, ACST-2 study group, By-Band-Sleeve study group, Chemorad study group, CSAW study group, Optima prelim study group, POUT study group, Leila Rooshenas, Daisy Elliott, Julia Wade, Marcus Jepson, Sangeetha Paramasivan, Sean Strong, Caroline Wilson, David Beard, Jane M Blazeby, Alison Birtle, Alison Halliday, Chris A Rogers, Rob Stein, Jenny L Donovan, ACST-2 study group, By-Band-Sleeve study group, Chemorad study group, CSAW study group, Optima prelim study group, POUT study group

Abstract

Background: Randomised controlled trials (RCTs) are essential for evidence-based medicine and increasingly rely on front-line clinicians to recruit eligible patients. Clinicians' difficulties with negotiating equipoise is assumed to undermine recruitment, although these issues have not yet been empirically investigated in the context of observable events. We aimed to investigate how clinicians conveyed equipoise during RCT recruitment appointments across six RCTs, with a view to (i) identifying practices that supported or hindered equipoise communication and (ii) exploring how clinicians' reported intentions compared with their actual practices.

Methods and findings: Six pragmatic UK-based RCTs were purposefully selected to include several clinical specialties (e.g., oncology, surgery) and types of treatment comparison. The RCTs were all based in secondary-care hospitals (n = 16) around the UK. Clinicians recruiting to the RCTs were interviewed (n = 23) to understand their individual sense of equipoise about the RCT treatments and their intentions for communicating equipoise to patients. Appointments in which these clinicians presented the RCT to trial-eligible patients were audio-recorded (n = 105). The appointments were analysed using thematic and content analysis approaches to identify practices that supported or challenged equipoise communication. A sample of appointments was independently coded by three researchers to optimise reliability in reported findings. Clinicians and patients provided full written consent to be interviewed and have appointments audio-recorded. Interviews revealed that clinicians' sense of equipoise varied: although all were uncertain about which trial treatment was optimal, they expressed different levels of uncertainty, ranging from complete ambivalence to clear beliefs that one treatment was superior. Irrespective of their personal views, all clinicians intended to set their personal biases aside to convey trial treatments neutrally to patients (in accordance with existing evidence). However, equipoise was omitted or compromised in 48/105 (46%) of the recorded appointments. Three commonly recurring practices compromised equipoise communication across the RCTs, irrespective of clinical context. First, equipoise was overridden by clinicians offering treatment recommendations when patients appeared unsure how to proceed or when they asked for the clinician's expert advice. Second, clinicians contradicted equipoise by presenting imbalanced descriptions of trial treatments that conflicted with scientific information stated in the RCT protocols. Third, equipoise was undermined by clinicians disclosing their personal opinions or predictions about trial outcomes, based on their intuition and experience. These broad practices were particularly demonstrated by clinicians who had indicated in interviews that they held less balanced views about trial treatments. A limitation of the study was that clinicians volunteering to take part in the research might have had a particular interest in improving their communication skills. However, the frequency of occurrence of equipoise issues across the RCTs suggests that the findings are likely to be reflective of clinical recruiters' practices more widely.

Conclusions: Communicating equipoise is a challenging process that is easily disrupted. Clinicians' personal views about trial treatments encroached on their ability to convey equipoise to patients. Clinicians should be encouraged to reflect on personal biases and be mindful of the common ways in which these can arise in their discussions with patients. Common pitfalls that recurred irrespective of RCT context indicate opportunities for specific training in communication skills that would be broadly applicable to a wide clinical audience.

Conflict of interest statement

The authors have declared that no competing interests exist. The authors declare no support from any organisation for the submitted work beyond those funding bodies declared in the manuscript.

Figures

Fig 1. Clinicians’ individual perceptions of equipoise,…
Fig 1. Clinicians’ individual perceptions of equipoise, based on interview accounts.

References

    1. Toerien M, Brookes ST, Metcalfe C, De Salis I, Tomlin Z, Peters TJ, et al. A review of reporting of participant recruitment and retention in RCTs in six major journals. Trials. 2009;10:52 10.1186/1745-6215-10-52
    1. Kasenda B, Von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, et al. Prevalence, characteristics, and publication of discontinued randomized trials. JAMA. 2014;311:1045–1052. 10.1001/jama.2014.1361
    1. Kitterman DR, Cheng SK, Dilts DM, Orwoll ES. The prevalence and economic impact of low-enrolling clinical studies at an academic medical center. Acad Med. 2011;86:1360 10.1097/ACM.0b013e3182306440
    1. Donovan JL, de Salis I, Toerien M, Paramasivan S, Hamdy FC, Blazeby JM. The intellectual challenges and emotional consequences of equipoise contributed to the fragility of recruitment in six randomized controlled trials. J Clin Epidemiol. 2014;67:912–920. 10.1016/j.jclinepi.2014.03.010
    1. Chard J, Lilford R. The use of equipoise in clinical trials. Soc Sci Med. 1998;47:891–898. 10.1016/s0277-9536(98)00153-1
    1. Djulbegovic B. The paradox of equipoise: the principle that drives and limits therapeutic discoveries in clinical research. Cancer Control. 2009;16:342–347.
    1. Horton R. Surgical research or comic opera: questions, but few answers. Lancet. 1996;347:984–985. 10.5555/uri:pii:S0140673696901373
    1. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317:141–145. 10.1056/nejm198707163170304
    1. Miller FG, Brody H. A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials. Hastings Cent Rep. 2003;33:19–28. 10.2307/3528434
    1. Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, et al. The uncertainty principle and industry-sponsored research. Lancet. 2000;356:635–638. 10.1016/s0140-6736(00)02605-2
    1. Madsen S, Holm S, Riis P. Attitudes towards clinical research among cancer trial participants and non-participants: an interview study using a Grounded Theory approach. J Med Ethics. 2007;33:234–240. 10.1136/jme.2005.015255
    1. Jackson CJ, Dixon-Woods M, Eborall H, Kenyon S, Tooz-Hobson P, Tincello D. Women’s views and experiences of a patient preference trial in surgery: a qualitative study of the CARPET1 trial. Clin Trials. 2010;7:696–704. 10.1177/1740774510381286
    1. Mills N, Donovan JL, Smith M, Jacoby A, Neal DE, Hamdy FC. Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study. Control Clin Trials. 2003;24:272–282. 10.1016/s0197-2456(03)00020-5
    1. Harrop E, Kelly J, Griffiths G, Casbard A, Nelson A. Why do patients decline surgical trials? Findings from a qualitative interview study embedded in the Cancer Research UK BOLERO trial (Bladder cancer: Open versus Lapararoscopic or RObotic cystectomy). Trials. 2016;17:35 10.1186/s13063-016-1173-z
    1. Taylor KM. Integrating conflicting professional roles: physician participation in randomized clinical trials. Soc Sci Med. 1992;35:217–224. 10.1016/0277-9536(92)90169-q
    1. Lawton J, Kirkham J, White D, Rankin D, Cooper C, Heller S. Uncovering the emotional aspects of working on a clinical trial: a qualitative study of the experiences and views of staff involved in a type 1 diabetes trial. Trials. 2015;16:3 10.1186/1745-6215-16-3
    1. Potter S, Mills N, Cawthorn SJ, Donovan J, Blazeby JM. Time to be BRAVE: is educating surgeons the key to unlocking the potential of randomised clinical trials in surgery? A qualitative study. Trials. 2014;15:80 10.1186/1745-6215-15-80
    1. Eborall HC, Dallosso HM, Daly H, Martin-Stacey L, Heller SR. The face of equipoise—delivering a structured education programme within a randomized controlled trial: qualitative study. Trials. 2014;15:6215–6215. 10.1186/1745-6215-15-15
    1. Miller FG, Joffe S. Equipoise and the dilemma of randomized clinical trials. N Engl J Med. 2011;364:476 10.1056/NEJMsb1011301
    1. Weijer C, Shapiro SH, Glass KC, Enkin MW. Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial. BMJ. 2000;321:756–759.
    1. University of Bristol School of Social and Community Medicine. Qualitative Research Integrated within Trials (QuinteT). 2016 [cited 8 Jun 2016]. Available: .
    1. Donovan JL, Rooshenas L, Jepson M, Elliott D, Wade J, Avery K, et al. Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI). Trials. 2016;17:1–11. 10.1186/s13063-016-1391-4
    1. Rogers CA, Welbourn R, Byrne J, Donovan JL, Reeves BC, Wordsworth S, et al. The By-Band study: gastric bypass or adjustable gastric band surgery to treat morbid obesity: study protocol for a multi-centre randomised controlled trial with an internal pilot phase. Trials. 2014;15:53 10.1186/1745-6215-15-53
    1. Birtle AJ, Lewis R, Johnson M, Hall E. Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (TCC)—opening of the peri‐operative chemotherapy versus surveillance in upper tract urothelial cancer (POUT) Trial. BJU Int. 2012;110:919–921. 10.1111/j.1464-410X.2012.11413.x
    1. Bartlett J, Canney P, Campbell A, Cameron D, Donovan J, Dunn J, et al. Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial. Clin Oncol. 2013;25:109–116. 10.1016/j.clon.2012.10.005
    1. Rudarakanchana N, Dialynas M, Halliday A. Asymptomatic Carotid Surgery Trial-2 (ACST-2): rationale for a randomised clinical trial comparing carotid endarterectomy with carotid artery stenting in patients with asymptomatic carotid artery stenosis. Eur J Vasc Endovasc Surg. 2009;38:239–242. 10.1016/j.ejvs.2009.05.010
    1. Beard D, Rees J, Rombach I, Cooper C, Cook J, Merritt N, et al. The CSAW Study (Can Shoulder Arthroscopy Work?)—a placebo-controlled surgical intervention trial assessing the clinical and cost effectiveness of arthroscopic subacromial decompression for shoulder pain: study protocol for a randomised controlled trial. Trials. 2015;16:210 10.1186/s13063-015-0725-y
    1. Blazeby J, Strong S, Donovan J, Wilson C, Hollingworth W, Crosby T, et al. Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer. Br J Cancer. 2014;111:234–240. 10.1038/bjc.2014.313
    1. Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research Chicago: Aldine; 1967.
    1. Donovan J, Mills N, Smith M, Brindle L, Jacoby A, Peters T, et al. Quality improvement report: improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. BMJ. 2002:766–769.
    1. Hamilton D, De Salis I, Donovan J, Birchall M. The recruitment of patients to trials in head and neck cancer: a qualitative study of the EaStER trial of treatments for early laryngeal cancer. Eur Arch Otorhinolaryngol. 2013;270:2333–2337. 10.1007/s00405-013-2349-8
    1. Jenkins V, Fallowfield L, Souhami A, Sawtell M. How do doctors explain randomised clinical trials to their patients? Eur J Cancer. 1999;35:1187–1193. 10.1016/s0959-8049(99)00116-1
    1. Byrne-Davis LM, Salmon P, Gravenhorst K, Eden TO, Young B. Balancing high accrual and ethical recruitment in paediatric oncology: a qualitative study of the’look and feel’of clinical trial discussions. BMC Med Res Methodol. 2010;10:101 10.1186/1471-2288-10-101
    1. Brown R, Butow P, Boyle F, Tattersall M. Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills training. Psychooncology. 2007;16:507–516.
    1. Garcia J, Elbourne D, Snowdon C. Equipoise: a case study of the views of clinicians involved in two neonatal trials. Clin Trials. 2004;1:170–178. 10.1191/1740774504cn020xx
    1. Han PK, Klein WM, Arora NK. Varieties of uncertainty in health care a conceptual taxonomy. Med Decis Making. 2011;31:828–838. 10.1177/0272989X11393976
    1. Griffiths F, Green E, Tsouroufli M. The nature of medical evidence and its inherent uncertainty for the clinical consultation: qualitative study. BMJ. 2005;330:511 10.1136/bmj.38336.482720.8F
    1. Pickles K, Carter SM, Rychetnik L, McCaffery K, Entwistle VA. General practitioners’ experiences of, and responses to, uncertainty in prostate cancer screening: insights from a qualitative study. PLoS ONE. 2016;11:e0153299 10.1371/journal.pone.0153299
    1. Tarn DM, Paterniti DA, Wenger NS. Provider recommendations in the face of scientific uncertainty: an analysis of audio-recorded discussions about vitamin D. J Gen Intern Med. 2016;31:909–917. 10.1007/s11606-016-3667-5
    1. Elwyn G, Edwards A, Kinnersley P, Grol R. Shared decision making and the concept of equipoise: the competences of involving patients in healthcare choices. Br J Gen Pract. 2000;50:892–899.
    1. Diamond-Brown L. The doctor-patient relationship as a toolkit for uncertain clinical decisions. Soc Sci Med. 2016;159:108–115. 10.1016/j.socscimed.2016.05.002
    1. Donovan JL, Paramasivan S, de Salis I, Toerien M. Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials. Trials. 2014;15:5 10.1186/1745-6215-15-5
    1. Kurzrock R, Stewart DJ. Equipoise abandoned? Randomization and clinical trials. Ann Oncol. 2013;24:2471–2474. 10.1093/annonc/mdt358
    1. Jenkins V, Fallowfield L, Solis-Trapala I, Langridge C, Farewell V. Discussing randomised clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme. BMJ. 2005;330:400 10.1136/bmj.38366.562685.8F
    1. Paramasivan S, Strong S, Wilson C, Campbell B, Blazeby JM, Donovan JL. A simple technique to identify key recruitment issues in randomised controlled trials: Q-QAT—Quanti-Qualitative Appointment Timing. Trials. 2015;16:88 10.1186/s13063-015-0617-1

Source: PubMed

3
S'abonner